Pharmaceuticals

Channel stocking in US in March quarter, lockdown impact hint at drop in earnings

Reliance of Indian pharma industry on Chinese APIs a 'huge strategic concern' with few short-term solutions, they say; meanwhile, CSIR says Covid offers a good opportunity to check brain drain

The drug will be available through the government and hospitals only, the company said

Experts attribute the higher payout to the change in dividend law and cut in corporate income tax.

Ties up with Fujifilm for exclusive rights over Avigan for Indian market, can sell overseas too

A senior official of the ministry of commerce said most of the goods that have to be cleared by the customs came from China

Remdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of Covid-19

The solution uses advanced analytics to manage individual patient treatment lifecycle from enrolment and scheduling to post medical treatments and can notably reduce patient treatment lifecycle

Nod for Ilumya, a specialty product, would strengthen firm's dermatology portfolio in Japan, but analysts caution that the segment has been witnessing price erosion of late

The surplus should not be a cause for any celebration

HCQ was dropped from the solidarity trial that WHO was conducting as a part of a global effort in May.

The moves come after the World Health Organization paused its large trial of hydroxychloroquine, prompting several European governments to ban the use of the drug

On a sequential basis, however, the company fared better, both in terms of sales and profits. The stock ended day's trade at Rs 869.8, down 1.3 per cent.

Pricing pressure in US, lockdown may dent near-term prospects

Within BSE-500, 79% stocks gave positive returns in two months of lockdown

For manufactured products, the stated policy since the 1950s was to allow imports of only the goods that were not being made in India in sufficient quantities

ICMR in its guidance clearly stated that these rapid antibody tests are not recommended for diagnosis of Covid-19 infection

China, S Korea stocks outperform as restrictions are rolled back

How India can make the most of the opportunity presented by the groundswell of emotion against China for its disinformation about coronavirus

Shortage of drugs in the US market is at five-year highs